Drug-sparing regimens for HIV combination therapy: Benefits predicted for ``drug coasting'' (Q2426381): Difference between revisions

From MaRDI portal
Added link to MaRDI item.
ReferenceBot (talk | contribs)
Changed an Item
 
(3 intermediate revisions by 3 users not shown)
Property / Wikidata QID
 
Property / Wikidata QID: Q51912232 / rank
 
Normal rank
Property / MaRDI profile type
 
Property / MaRDI profile type: MaRDI publication profile / rank
 
Normal rank
Property / full work available at URL
 
Property / full work available at URL: https://doi.org/10.1007/s11538-007-9234-9 / rank
 
Normal rank
Property / OpenAlex ID
 
Property / OpenAlex ID: W2039396792 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Predicting differential responses to structured treatment interruptions during HAART / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q4226762 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q4076577 / rank
 
Normal rank
Property / cites work
 
Property / cites work: A model for treatment strategy in the chemotherapy of AIDS / rank
 
Normal rank
Property / cites work
 
Property / cites work: Optimal control of the chemotherapy of HIV / rank
 
Normal rank
Property / cites work
 
Property / cites work: Costs versus benefits: best possible and best practical treatment regimens for HIV / rank
 
Normal rank
Property / cites work
 
Property / cites work: Optimal drug treatment regimens for HIV depend on adherence / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q4449282 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Mathematical Analysis of HIV-1 Dynamics in Vivo / rank
 
Normal rank

Latest revision as of 20:55, 27 June 2024

scientific article
Language Label Description Also known as
English
Drug-sparing regimens for HIV combination therapy: Benefits predicted for ``drug coasting''
scientific article

    Statements

    Drug-sparing regimens for HIV combination therapy: Benefits predicted for ``drug coasting'' (English)
    0 references
    0 references
    0 references
    22 April 2008
    0 references
    structured treatment interruptions
    0 references
    triple-drug therapy
    0 references
    HAART
    0 references
    toxicity
    0 references
    drug resistance
    0 references

    Identifiers